Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
Recruiting · NCT07485075 · Interventional (participants receive a specific treatment) · Lead sponsor: Steno Diabetes Center Copenhagen
View the official record on ClinicalTrials.gov →Interventions studied
StenoFood App
What this trial is about
This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).
Who can take part
Age range
18 Years to 74 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Type 2 diabetes (ICD-10 DE11.x)
- Age 18-74 years
- BMI \< 35 kg/m²
- eGFR 30-59 ml/min and UACR \> 30 mg/g
- Stable medication for ≥3 months
- Ability to read and understand Danish
Exclusion criteria
- Type 1 diabetes or other diabetes types
- Current vegan diet
- Active cancer
- Short bowel syndrome or celiac disease
- Use of sodium chloride tablets
- No access to digital platform (intervention group only)
Where it is running
2 locations listed.
- Steno Diabetes Center Copenhagen, - Herlev, Captial Region of Denmark, Denmark
- Nordsjællands Hospital, Hillerød - Hillerød, Captial Region of Denmark, Denmark